Pregnancy and thyroid pathology


DOI: https://dx.doi.org/10.18565/therapy.2020.1.96-102

Petunina N.A., Trukhina L.V., Petunina V.V., Martirosyan N.S.

1) I.M. Sechenov First Moscow State medical University of the Ministry of Healthcare of Russia (Sechenov University); 2) N.I. Pirogov Russian National research medical University of the Ministry of Healthcare of Russia, Moscow
Different forms of thyroid dysfunction are frequent in women of reproductive age. Thyroid hormones play a significant role in organogenesis, development and function of all organs and systems. For this reason both lack and excess of thyroid hormones are associated with high-risk pregnancy and birth. There`s no doubt about the tactics of management of thyroid dysfunction manifest forms but issue of diagnostics and treatment of subclinical hypothyroidism as well as problem of management of pregnant women with isolated hypothyroxinemia and thyroid antibodies status remain open. High prevalence of thyroid pathology in the general population and living in the regions with severe and moderate iodine deficiency give relevance to screening for thyroid dysfunction in early pregnancy.
Keywords: thyroid antibodies status, isolated hypothyroxinemia, subclinical thyrotoxicosis, manifest hyperthyroidism, manifest hypothyroidism, subclinical hypothyroidism, thyroid, pregnancy
Read entire article

Literature


  1. Haddow J.E., Knight G.J., Palomaki G.E., McClain M.R., Pulkkinen A.J. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen. 2004; 11: 170–74.

  2. Zimmermann M.B., Gizak M., Abbott K. et al. Iodine deficiency in pregnant women in Europe. Lancet Diabetes Endocrinol. 2015 Sep; 3: 672–74. doi: 10.1016/S2213-8587(15)00263-6.

  3. Alexander E.K., Pearce E.N., Brent G.A. et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017 Mar; 27(3): 315–89.doi: 10.1089/thy.2016.0457.

  4. Dong A.C., Stagnaro-Green A. Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: a systematic review and meta-analysis. Thyroid. 2019 Feb; 29(2): 278–89. doi: 10.1089/thy.2018.0475.

  5. Springer D., Jiskra J., Limanova Z., Zima T., Potlukova E. Thyroid in pregnancy: from physiology to screening. Crit Rev Clin Lab Sci. 2017 Mar; 54(2): 102–16. doi: 10.1080/10408363.2016.1269309.

  6. Stagnaro-Green A., Abalovich M., Alexander E. et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum: the American Thyroid Association Taskforce on thyroid disease during pregnancy and postpartum. Thyroid 2011 Oct; 21(10): 1081–125. doi: 10.1089/thy.2011.0087.

  7. Toloza F.J.K., Singh Ospina N.M., Rodriguez-Gutierrez R. et al. Practice variation in the care of subclinical hypothyroidism during pregnancy – a national survey of physicians in the U.S. J Endocr Soc. 2019 Aug 1; 3(10): 1892–906.doi: 10.1210/js.2019-00196.

  8. Thompson W., Russell G., Baragwanath G. et al. Maternal thyroid hormone insufficiency during pregnancy and risk of neurodevelopmental disorders in offspring: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018 Apr; 88(4): 575–84. doi: 10.1111/cen.13550.

  9. Lazarus J.H., Bestwick J.P., Channon S. et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012 Feb 9; 366(6): 493–501. doi: 10.1056/NEJMoa1106104.

  10. Bowman P., Vaidya B. Suspected spontaneous reports of birth defects in the UK associated with the use of carbimazole and propylthiouracil in pregnancy. J Thyroid Res. 2011; 2011: 235130. doi: 10.4061/2011/235130.

  11. Casey B.M., Dashe J.S., Wells C.E., McIntire D.D., Leveno K.J., Cunningham F.G. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006 Feb; 107(2 Pt 1): 337–41.

  12. Lazarus J.H., Brown R.S., Daumerie C., Hubalewska-Dydejczyk A., Negro R., Vaidya B. European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014; 3: 76–94.doi: 10.1159/000362597.

  13. Yang J., Liu Y., Liu H. et al. Associations of maternal iodine status and thyroid function with adverse pregnancy outcomes in Henan Province of China. J Trace Elem Med Biol. 2018 May; 47: 104–10. doi: 10.1016/j.jtemb.2018.01.013.

  14. Breathnach F.M., Donnelly J., Cooley S.M. et al. Subclinical hypothyroidism as a risk factor for placental abruption: evidence from a low-risk primigravid population. Aust N Z J Obstet Gynaecol. 2013; 53: 553–60. doi: 10.1111/ajo.12131.

  15. Ghassabian A., El Marroun H., Peeters R.P. et al. Downstream effects of maternal hypothyroxinemia in early pregnancy: nonverbal IQ and brain morphology in school-age children. J Clin Endocrinol Metab. 2014 Jul; 99(7): 2383–90. doi: 10.1210/jc.2013-4281.

  16. Casey B.M., Thom E.A., Peaceman A.M. et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017; 376: 815–25. doi: 10.1056/NEJMoa1606205.

  17. Hales C., Taylor P.N., Channon S. et al. Controlled antenatal thyroid screening II: effect of treating maternal suboptimal thyroid function on child cognition. J Clin Endocrinol Metabol. 2018; 103: 1583–91. https://doi.org/10.1210/jc.2017-02378.

  18. Thangaratinam S., Tan A., Knox E. et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 2011; 9: d2616. doi: 10.1136/bmj.d2616.

  19. Bliddal S., Feldt-Rasmussen U., Rasmussen Å.K. et al. Thyroid peroxidase antibodies and prospective live birth rate: a cohort study of women with recurrent pregnancy loss. Thyroid. 2019 Oct; 29(10): 1465–74. doi: 10.1089/thy.2019.0077.

  20. Minaldi E., D’Andrea S., Castellini C. et al. Thyroid autoimmunity and risk of post‑partum depression: a systematic review and meta‑analysis of longitudinal studies. J Endocrinol Invest. 2019 Sep 24. doi: 10.1007/s40618-019-01120-8.


About the Autors

Nina A. Petunina, MD, professor, head of the Department of endocrinology of I.M. Sechenov First Moscow State medical University of the Ministry of Healthcare of Russia (Sechenov University). Address: 119991, Moscow, 8/2 Trubetskaya Str. Tel.: +7 (495) 530-32-16. E-mail: napetunina@mail.ru
Lybov V. Trukhina, PhD, associate professor of the Department of endocrinology of I.M. Sechenov First Moscow State medical University of the Ministry of Healthcare of Russia (Sechenov University). Address: 119991, Moscow, 8/2 Trubetskaya Str. Tel.: +7 (495) 530-33-13. E-mail: lvtruhina@gmail.com
Valentina V. Petunina, PhD, associate professor of the Department of skin diseases and cosmetology of faculty of additional professional education of N.I. Pirogov Russian scientific medical university of the Ministry of Healthcare of Russia. Address: 117997, Moscow, 1 Ostrovityaninova Str. Tel.: +7 (495) 954-53-97.
Narine S. Martirosyan, PhD, assistant of the Department of endocrinology of I.M. Sechenov First Moscow State medical University of the Ministry of Healthcare of Russia (Sechenov University). Address: 119991, Moscow, 8/2 Trubetskaya Str. Tel.: +7 (495) 530-33-13. E-mail: narinarine@list.ru


Similar Articles

Back to Content

Бионика Медиа